Key Events This Week
11 May: Stock hits lower circuit amid heavy selling pressure
12 May: Sharp rebound with upper circuit surge on strong buying interest
15 May: Week closes at Rs.46.72, down 8.21% from previous Friday
May 20
BSE+NSE Vol: 78.83 k

Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
At Rs 48.42, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.53% on 19 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
11 May: Stock hits lower circuit amid heavy selling pressure
12 May: Sharp rebound with upper circuit surge on strong buying interest
15 May: Week closes at Rs.46.72, down 8.21% from previous Friday

At Rs 49.83, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 3.88% on 12 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
At Rs 48.4, Brooks Laboratories Ltd locked at its lower circuit on 11 May 2026, reflecting a 3.06% decline within a 5% price band. Despite sellers lining up to exit, there were no buyers willing to absorb the supply, resulting in a freeze at the floor price and unfilled sell orders that highlight the stock’s current liquidity challenges.
Read full news article
May 4: Brooks Laboratories Ltd hits upper circuit amid strong buying pressure
May 6: Stock surges again to upper circuit, reversing six-day losing streak
May 8: Heavy selling drives stock to lower circuit limit

Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
At Rs 49.93, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 4.99% on 8 May 2026, with unfilled sell orders and a frozen price that capped losses for the session.
Read full news article
At Rs 56.97, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.94% on 6 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news articleBrooks Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transactions for the half year ended September 30, 2019.
Brooks Laboratories Limited has informed the Exchange regarding a press release dated November 15, 2019, titled "Unaudited Financial Results for the 2nd quarter and half year ended 30.09.2019".
Brooks Laboratories Limited has informed the Exchange regarding Reappointment of Auditor of the company.
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Brooks Laboratories Ltd has announced 1:16 rights issue, ex-date: 28 Jul 23